A real-world comparison of clinical effectiveness in patients with rheumatoid arthritis treated with upadacitinib, tumor necrosis factor inhibitors, and other advanced therapies after switching from an initial tumor necrosis factor inhibitor

A real-world comparison of clinical effectiveness in patients with rheumatoid arthritis treated with upadacitinib, tumor necrosis factor inhibitors, and other advanced therapies after switching from an initial tumor necrosis factor inhibitor

Show other versions (1)

<p><strong>INTRODUCTION:</strong> This study compared the clinical effectiveness of switching from tumor necrosis factor inhibitor (TNFi) to upadacitinib (TNFi-UPA), another TNFi (TNFi-TNFi), or an advanced therapy with another mechanism of action (TNFi-other MOA) in patients with...

Full description

Bibliographic Details
Main Authors: Caporali, R, Kadakia, A, Howell, O, Patel, J, Milligan, J, Strengholt, S, Barlow, S, Taylor, PC
Format: Journal article
Language:English
Published: Springer 2024

Similar Items

Similar Items